Clinical Trial Update: A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes [Phase 3]

View source ↗

Summary

This entry summarizes an ongoing Phase 3 trial evaluating VX-880 for Type 1 diabetes mellitus, including patients with impaired hypoglycemic awareness, with the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoglycemia
• Impaired Awareness of Hypoglycemia
• Type 1 Diabetes Mellitus

Drugs mentioned

• VX-880

Snippet

Sponsor: Vertex Pharmaceuticals Incorporated | Conditions: Diabetes Mellitus, Type 1, Impaired Hypoglycemic Awareness | Phase 3 | Status: RECRUITING